Global Pet OTC Medication Market Growth 2026-2032
The global Pet OTC Medication market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 51%.
LP Information, Inc. (LPI) ' newest research report, the ?Pet OTC Medication Industry Forecast? looks at past sales and reviews total world Pet OTC Medication sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet OTC Medication sales for 2026 through 2032. With Pet OTC Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet OTC Medication industry.
This Insight Report provides a comprehensive analysis of the global Pet OTC Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet OTC Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pet OTC Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet OTC Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet OTC Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet OTC Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 51%.
LP Information, Inc. (LPI) ' newest research report, the ?Pet OTC Medication Industry Forecast? looks at past sales and reviews total world Pet OTC Medication sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet OTC Medication sales for 2026 through 2032. With Pet OTC Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet OTC Medication industry.
This Insight Report provides a comprehensive analysis of the global Pet OTC Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet OTC Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pet OTC Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet OTC Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet OTC Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet OTC Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablets
- Capsules
- Sprays
- Pet Specialty Stores
- Veterinary Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer AG
- Boehringer Ingelheim International GmbH
- Covetrus
- Dechra Pharmaceuticals
- Elanco Animal Health
- Heska
- IDEXX Laboratories
- Kyoritsu Seiyaku
- Merck & Co.
- Phibro Animal Health
- Sequent Scientific
- Vetoquinol SA
- Virbac SA
- Zoetis
- What is the 10-year outlook for the global Pet OTC Medication market?
- What factors are driving Pet OTC Medication market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Pet OTC Medication market opportunities vary by end market size?
- How does Pet OTC Medication break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet OTC Medication Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pet OTC Medication by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pet OTC Medication by Country/Region, 2021, 2025 & 2032
2.2 Pet OTC Medication Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Sprays
2.2.4 Pet OTC Medication Sales by Type
2.2.4.1 Global Pet OTC Medication Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pet OTC Medication Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pet OTC Medication Sale Price by Type (2021-2026)
2.3 Pet OTC Medication Segment by Application
2.3.1 Pet Specialty Stores
2.3.2 Veterinary Clinics
2.3.3 Others
2.3.4 Pet OTC Medication Sales by Application
2.3.4.1 Global Pet OTC Medication Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pet OTC Medication Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pet OTC Medication Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pet OTC Medication Breakdown Data by Company
3.1.1 Global Pet OTC Medication Annual Sales by Company (2021-2026)
3.1.2 Global Pet OTC Medication Sales Market Share by Company (2021-2026)
3.2 Global Pet OTC Medication Annual Revenue by Company (2021-2026)
3.2.1 Global Pet OTC Medication Revenue by Company (2021-2026)
3.2.2 Global Pet OTC Medication Revenue Market Share by Company (2021-2026)
3.3 Global Pet OTC Medication Sale Price by Company
3.4 Key Manufacturers Pet OTC Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet OTC Medication Product Location Distribution
3.4.2 Players Pet OTC Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET OTC MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Pet OTC Medication Market Size by Geographic Region (2021-2026)
4.1.1 Global Pet OTC Medication Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pet OTC Medication Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pet OTC Medication Market Size by Country/Region (2021-2026)
4.2.1 Global Pet OTC Medication Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pet OTC Medication Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet OTC Medication Sales Growth
4.4 APAC Pet OTC Medication Sales Growth
4.5 Europe Pet OTC Medication Sales Growth
4.6 Middle East & Africa Pet OTC Medication Sales Growth
5 AMERICAS
5.1 Americas Pet OTC Medication Sales by Country
5.1.1 Americas Pet OTC Medication Sales by Country (2021-2026)
5.1.2 Americas Pet OTC Medication Revenue by Country (2021-2026)
5.2 Americas Pet OTC Medication Sales by Type (2021-2026)
5.3 Americas Pet OTC Medication Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet OTC Medication Sales by Region
6.1.1 APAC Pet OTC Medication Sales by Region (2021-2026)
6.1.2 APAC Pet OTC Medication Revenue by Region (2021-2026)
6.2 APAC Pet OTC Medication Sales by Type (2021-2026)
6.3 APAC Pet OTC Medication Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet OTC Medication by Country
7.1.1 Europe Pet OTC Medication Sales by Country (2021-2026)
7.1.2 Europe Pet OTC Medication Revenue by Country (2021-2026)
7.2 Europe Pet OTC Medication Sales by Type (2021-2026)
7.3 Europe Pet OTC Medication Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet OTC Medication by Country
8.1.1 Middle East & Africa Pet OTC Medication Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pet OTC Medication Revenue by Country (2021-2026)
8.2 Middle East & Africa Pet OTC Medication Sales by Type (2021-2026)
8.3 Middle East & Africa Pet OTC Medication Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet OTC Medication
10.3 Manufacturing Process Analysis of Pet OTC Medication
10.4 Industry Chain Structure of Pet OTC Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet OTC Medication Distributors
11.3 Pet OTC Medication Customer
12 WORLD FORECAST REVIEW FOR PET OTC MEDICATION BY GEOGRAPHIC REGION
12.1 Global Pet OTC Medication Market Size Forecast by Region
12.1.1 Global Pet OTC Medication Forecast by Region (2027-2032)
12.1.2 Global Pet OTC Medication Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pet OTC Medication Forecast by Type (2027-2032)
12.7 Global Pet OTC Medication Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Pet OTC Medication Product Portfolios and Specifications
13.1.3 Bayer AG Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Boehringer Ingelheim International GmbH
13.2.1 Boehringer Ingelheim International GmbH Company Information
13.2.2 Boehringer Ingelheim International GmbH Pet OTC Medication Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim International GmbH Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim International GmbH Main Business Overview
13.2.5 Boehringer Ingelheim International GmbH Latest Developments
13.3 Covetrus
13.3.1 Covetrus Company Information
13.3.2 Covetrus Pet OTC Medication Product Portfolios and Specifications
13.3.3 Covetrus Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Covetrus Main Business Overview
13.3.5 Covetrus Latest Developments
13.4 Dechra Pharmaceuticals
13.4.1 Dechra Pharmaceuticals Company Information
13.4.2 Dechra Pharmaceuticals Pet OTC Medication Product Portfolios and Specifications
13.4.3 Dechra Pharmaceuticals Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dechra Pharmaceuticals Main Business Overview
13.4.5 Dechra Pharmaceuticals Latest Developments
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Company Information
13.5.2 Elanco Animal Health Pet OTC Medication Product Portfolios and Specifications
13.5.3 Elanco Animal Health Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Elanco Animal Health Main Business Overview
13.5.5 Elanco Animal Health Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Pet OTC Medication Product Portfolios and Specifications
13.6.3 Heska Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 IDEXX Laboratories
13.7.1 IDEXX Laboratories Company Information
13.7.2 IDEXX Laboratories Pet OTC Medication Product Portfolios and Specifications
13.7.3 IDEXX Laboratories Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IDEXX Laboratories Main Business Overview
13.7.5 IDEXX Laboratories Latest Developments
13.8 Kyoritsu Seiyaku
13.8.1 Kyoritsu Seiyaku Company Information
13.8.2 Kyoritsu Seiyaku Pet OTC Medication Product Portfolios and Specifications
13.8.3 Kyoritsu Seiyaku Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kyoritsu Seiyaku Main Business Overview
13.8.5 Kyoritsu Seiyaku Latest Developments
13.9 Merck & Co.
13.9.1 Merck & Co. Company Information
13.9.2 Merck & Co. Pet OTC Medication Product Portfolios and Specifications
13.9.3 Merck & Co. Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck & Co. Main Business Overview
13.9.5 Merck & Co. Latest Developments
13.10 Phibro Animal Health
13.10.1 Phibro Animal Health Company Information
13.10.2 Phibro Animal Health Pet OTC Medication Product Portfolios and Specifications
13.10.3 Phibro Animal Health Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Phibro Animal Health Main Business Overview
13.10.5 Phibro Animal Health Latest Developments
13.11 Sequent Scientific
13.11.1 Sequent Scientific Company Information
13.11.2 Sequent Scientific Pet OTC Medication Product Portfolios and Specifications
13.11.3 Sequent Scientific Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sequent Scientific Main Business Overview
13.11.5 Sequent Scientific Latest Developments
13.12 Vetoquinol SA
13.12.1 Vetoquinol SA Company Information
13.12.2 Vetoquinol SA Pet OTC Medication Product Portfolios and Specifications
13.12.3 Vetoquinol SA Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Vetoquinol SA Main Business Overview
13.12.5 Vetoquinol SA Latest Developments
13.13 Virbac SA
13.13.1 Virbac SA Company Information
13.13.2 Virbac SA Pet OTC Medication Product Portfolios and Specifications
13.13.3 Virbac SA Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Virbac SA Main Business Overview
13.13.5 Virbac SA Latest Developments
13.14 Zoetis
13.14.1 Zoetis Company Information
13.14.2 Zoetis Pet OTC Medication Product Portfolios and Specifications
13.14.3 Zoetis Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Zoetis Main Business Overview
13.14.5 Zoetis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet OTC Medication Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pet OTC Medication by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pet OTC Medication by Country/Region, 2021, 2025 & 2032
2.2 Pet OTC Medication Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Sprays
2.2.4 Pet OTC Medication Sales by Type
2.2.4.1 Global Pet OTC Medication Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pet OTC Medication Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pet OTC Medication Sale Price by Type (2021-2026)
2.3 Pet OTC Medication Segment by Application
2.3.1 Pet Specialty Stores
2.3.2 Veterinary Clinics
2.3.3 Others
2.3.4 Pet OTC Medication Sales by Application
2.3.4.1 Global Pet OTC Medication Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pet OTC Medication Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pet OTC Medication Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pet OTC Medication Breakdown Data by Company
3.1.1 Global Pet OTC Medication Annual Sales by Company (2021-2026)
3.1.2 Global Pet OTC Medication Sales Market Share by Company (2021-2026)
3.2 Global Pet OTC Medication Annual Revenue by Company (2021-2026)
3.2.1 Global Pet OTC Medication Revenue by Company (2021-2026)
3.2.2 Global Pet OTC Medication Revenue Market Share by Company (2021-2026)
3.3 Global Pet OTC Medication Sale Price by Company
3.4 Key Manufacturers Pet OTC Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet OTC Medication Product Location Distribution
3.4.2 Players Pet OTC Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET OTC MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Pet OTC Medication Market Size by Geographic Region (2021-2026)
4.1.1 Global Pet OTC Medication Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pet OTC Medication Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pet OTC Medication Market Size by Country/Region (2021-2026)
4.2.1 Global Pet OTC Medication Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pet OTC Medication Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet OTC Medication Sales Growth
4.4 APAC Pet OTC Medication Sales Growth
4.5 Europe Pet OTC Medication Sales Growth
4.6 Middle East & Africa Pet OTC Medication Sales Growth
5 AMERICAS
5.1 Americas Pet OTC Medication Sales by Country
5.1.1 Americas Pet OTC Medication Sales by Country (2021-2026)
5.1.2 Americas Pet OTC Medication Revenue by Country (2021-2026)
5.2 Americas Pet OTC Medication Sales by Type (2021-2026)
5.3 Americas Pet OTC Medication Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet OTC Medication Sales by Region
6.1.1 APAC Pet OTC Medication Sales by Region (2021-2026)
6.1.2 APAC Pet OTC Medication Revenue by Region (2021-2026)
6.2 APAC Pet OTC Medication Sales by Type (2021-2026)
6.3 APAC Pet OTC Medication Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet OTC Medication by Country
7.1.1 Europe Pet OTC Medication Sales by Country (2021-2026)
7.1.2 Europe Pet OTC Medication Revenue by Country (2021-2026)
7.2 Europe Pet OTC Medication Sales by Type (2021-2026)
7.3 Europe Pet OTC Medication Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet OTC Medication by Country
8.1.1 Middle East & Africa Pet OTC Medication Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pet OTC Medication Revenue by Country (2021-2026)
8.2 Middle East & Africa Pet OTC Medication Sales by Type (2021-2026)
8.3 Middle East & Africa Pet OTC Medication Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet OTC Medication
10.3 Manufacturing Process Analysis of Pet OTC Medication
10.4 Industry Chain Structure of Pet OTC Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet OTC Medication Distributors
11.3 Pet OTC Medication Customer
12 WORLD FORECAST REVIEW FOR PET OTC MEDICATION BY GEOGRAPHIC REGION
12.1 Global Pet OTC Medication Market Size Forecast by Region
12.1.1 Global Pet OTC Medication Forecast by Region (2027-2032)
12.1.2 Global Pet OTC Medication Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pet OTC Medication Forecast by Type (2027-2032)
12.7 Global Pet OTC Medication Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Pet OTC Medication Product Portfolios and Specifications
13.1.3 Bayer AG Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Boehringer Ingelheim International GmbH
13.2.1 Boehringer Ingelheim International GmbH Company Information
13.2.2 Boehringer Ingelheim International GmbH Pet OTC Medication Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim International GmbH Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim International GmbH Main Business Overview
13.2.5 Boehringer Ingelheim International GmbH Latest Developments
13.3 Covetrus
13.3.1 Covetrus Company Information
13.3.2 Covetrus Pet OTC Medication Product Portfolios and Specifications
13.3.3 Covetrus Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Covetrus Main Business Overview
13.3.5 Covetrus Latest Developments
13.4 Dechra Pharmaceuticals
13.4.1 Dechra Pharmaceuticals Company Information
13.4.2 Dechra Pharmaceuticals Pet OTC Medication Product Portfolios and Specifications
13.4.3 Dechra Pharmaceuticals Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dechra Pharmaceuticals Main Business Overview
13.4.5 Dechra Pharmaceuticals Latest Developments
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Company Information
13.5.2 Elanco Animal Health Pet OTC Medication Product Portfolios and Specifications
13.5.3 Elanco Animal Health Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Elanco Animal Health Main Business Overview
13.5.5 Elanco Animal Health Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Pet OTC Medication Product Portfolios and Specifications
13.6.3 Heska Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 IDEXX Laboratories
13.7.1 IDEXX Laboratories Company Information
13.7.2 IDEXX Laboratories Pet OTC Medication Product Portfolios and Specifications
13.7.3 IDEXX Laboratories Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IDEXX Laboratories Main Business Overview
13.7.5 IDEXX Laboratories Latest Developments
13.8 Kyoritsu Seiyaku
13.8.1 Kyoritsu Seiyaku Company Information
13.8.2 Kyoritsu Seiyaku Pet OTC Medication Product Portfolios and Specifications
13.8.3 Kyoritsu Seiyaku Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kyoritsu Seiyaku Main Business Overview
13.8.5 Kyoritsu Seiyaku Latest Developments
13.9 Merck & Co.
13.9.1 Merck & Co. Company Information
13.9.2 Merck & Co. Pet OTC Medication Product Portfolios and Specifications
13.9.3 Merck & Co. Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck & Co. Main Business Overview
13.9.5 Merck & Co. Latest Developments
13.10 Phibro Animal Health
13.10.1 Phibro Animal Health Company Information
13.10.2 Phibro Animal Health Pet OTC Medication Product Portfolios and Specifications
13.10.3 Phibro Animal Health Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Phibro Animal Health Main Business Overview
13.10.5 Phibro Animal Health Latest Developments
13.11 Sequent Scientific
13.11.1 Sequent Scientific Company Information
13.11.2 Sequent Scientific Pet OTC Medication Product Portfolios and Specifications
13.11.3 Sequent Scientific Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sequent Scientific Main Business Overview
13.11.5 Sequent Scientific Latest Developments
13.12 Vetoquinol SA
13.12.1 Vetoquinol SA Company Information
13.12.2 Vetoquinol SA Pet OTC Medication Product Portfolios and Specifications
13.12.3 Vetoquinol SA Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Vetoquinol SA Main Business Overview
13.12.5 Vetoquinol SA Latest Developments
13.13 Virbac SA
13.13.1 Virbac SA Company Information
13.13.2 Virbac SA Pet OTC Medication Product Portfolios and Specifications
13.13.3 Virbac SA Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Virbac SA Main Business Overview
13.13.5 Virbac SA Latest Developments
13.14 Zoetis
13.14.1 Zoetis Company Information
13.14.2 Zoetis Pet OTC Medication Product Portfolios and Specifications
13.14.3 Zoetis Pet OTC Medication Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Zoetis Main Business Overview
13.14.5 Zoetis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet OTC Medication Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pet OTC Medication Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Major Players of Sprays
Table 6. Global Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 7. Global Pet OTC Medication Sales Market Share by Type (2021-2026)
Table 8. Global Pet OTC Medication Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pet OTC Medication Revenue Market Share by Type (2021-2026)
Table 10. Global Pet OTC Medication Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Pet OTC Medication Sale by Application (2021-2026) & (K Units)
Table 12. Global Pet OTC Medication Sale Market Share by Application (2021-2026)
Table 13. Global Pet OTC Medication Revenue by Application (2021-2026) & ($ million)
Table 14. Global Pet OTC Medication Revenue Market Share by Application (2021-2026)
Table 15. Global Pet OTC Medication Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Pet OTC Medication Sales by Company (2021-2026) & (K Units)
Table 17. Global Pet OTC Medication Sales Market Share by Company (2021-2026)
Table 18. Global Pet OTC Medication Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Pet OTC Medication Revenue Market Share by Company (2021-2026)
Table 20. Global Pet OTC Medication Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Pet OTC Medication Producing Area Distribution and Sales Area
Table 22. Players Pet OTC Medication Products Offered
Table 23. Pet OTC Medication Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet OTC Medication Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Pet OTC Medication Sales Market Share Geographic Region (2021-2026)
Table 28. Global Pet OTC Medication Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Pet OTC Medication Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Pet OTC Medication Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Pet OTC Medication Sales Market Share by Country/Region (2021-2026)
Table 32. Global Pet OTC Medication Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Pet OTC Medication Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 35. Americas Pet OTC Medication Sales Market Share by Country (2021-2026)
Table 36. Americas Pet OTC Medication Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 38. Americas Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 39. APAC Pet OTC Medication Sales by Region (2021-2026) & (K Units)
Table 40. APAC Pet OTC Medication Sales Market Share by Region (2021-2026)
Table 41. APAC Pet OTC Medication Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 43. APAC Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 44. Europe Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 45. Europe Pet OTC Medication Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 47. Europe Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Pet OTC Medication Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Pet OTC Medication
Table 53. Key Market Challenges & Risks of Pet OTC Medication
Table 54. Key Industry Trends of Pet OTC Medication
Table 55. Pet OTC Medication Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet OTC Medication Distributors List
Table 58. Pet OTC Medication Customer List
Table 59. Global Pet OTC Medication Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Pet OTC Medication Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Pet OTC Medication Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Pet OTC Medication Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Pet OTC Medication Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Pet OTC Medication Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Pet OTC Medication Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Pet OTC Medication Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Pet OTC Medication Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Pet OTC Medication Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Pet OTC Medication Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Bayer AG Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 74. Bayer AG Pet OTC Medication Product Portfolios and Specifications
Table 75. Bayer AG Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Bayer AG Main Business
Table 77. Bayer AG Latest Developments
Table 78. Boehringer Ingelheim International GmbH Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim International GmbH Pet OTC Medication Product Portfolios and Specifications
Table 80. Boehringer Ingelheim International GmbH Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boehringer Ingelheim International GmbH Main Business
Table 82. Boehringer Ingelheim International GmbH Latest Developments
Table 83. Covetrus Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 84. Covetrus Pet OTC Medication Product Portfolios and Specifications
Table 85. Covetrus Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Covetrus Main Business
Table 87. Covetrus Latest Developments
Table 88. Dechra Pharmaceuticals Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 89. Dechra Pharmaceuticals Pet OTC Medication Product Portfolios and Specifications
Table 90. Dechra Pharmaceuticals Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Dechra Pharmaceuticals Main Business
Table 92. Dechra Pharmaceuticals Latest Developments
Table 93. Elanco Animal Health Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Animal Health Pet OTC Medication Product Portfolios and Specifications
Table 95. Elanco Animal Health Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Elanco Animal Health Main Business
Table 97. Elanco Animal Health Latest Developments
Table 98. Heska Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 99. Heska Pet OTC Medication Product Portfolios and Specifications
Table 100. Heska Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Heska Main Business
Table 102. Heska Latest Developments
Table 103. IDEXX Laboratories Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 104. IDEXX Laboratories Pet OTC Medication Product Portfolios and Specifications
Table 105. IDEXX Laboratories Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. IDEXX Laboratories Main Business
Table 107. IDEXX Laboratories Latest Developments
Table 108. Kyoritsu Seiyaku Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 109. Kyoritsu Seiyaku Pet OTC Medication Product Portfolios and Specifications
Table 110. Kyoritsu Seiyaku Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kyoritsu Seiyaku Main Business
Table 112. Kyoritsu Seiyaku Latest Developments
Table 113. Merck & Co. Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck & Co. Pet OTC Medication Product Portfolios and Specifications
Table 115. Merck & Co. Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Merck & Co. Main Business
Table 117. Merck & Co. Latest Developments
Table 118. Phibro Animal Health Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 119. Phibro Animal Health Pet OTC Medication Product Portfolios and Specifications
Table 120. Phibro Animal Health Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Phibro Animal Health Main Business
Table 122. Phibro Animal Health Latest Developments
Table 123. Sequent Scientific Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 124. Sequent Scientific Pet OTC Medication Product Portfolios and Specifications
Table 125. Sequent Scientific Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Sequent Scientific Main Business
Table 127. Sequent Scientific Latest Developments
Table 128. Vetoquinol SA Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 129. Vetoquinol SA Pet OTC Medication Product Portfolios and Specifications
Table 130. Vetoquinol SA Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Vetoquinol SA Main Business
Table 132. Vetoquinol SA Latest Developments
Table 133. Virbac SA Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 134. Virbac SA Pet OTC Medication Product Portfolios and Specifications
Table 135. Virbac SA Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Virbac SA Main Business
Table 137. Virbac SA Latest Developments
Table 138. Zoetis Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 139. Zoetis Pet OTC Medication Product Portfolios and Specifications
Table 140. Zoetis Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Zoetis Main Business
Table 142. Zoetis Latest Developments
Table 1. Pet OTC Medication Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pet OTC Medication Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Major Players of Sprays
Table 6. Global Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 7. Global Pet OTC Medication Sales Market Share by Type (2021-2026)
Table 8. Global Pet OTC Medication Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pet OTC Medication Revenue Market Share by Type (2021-2026)
Table 10. Global Pet OTC Medication Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Pet OTC Medication Sale by Application (2021-2026) & (K Units)
Table 12. Global Pet OTC Medication Sale Market Share by Application (2021-2026)
Table 13. Global Pet OTC Medication Revenue by Application (2021-2026) & ($ million)
Table 14. Global Pet OTC Medication Revenue Market Share by Application (2021-2026)
Table 15. Global Pet OTC Medication Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Pet OTC Medication Sales by Company (2021-2026) & (K Units)
Table 17. Global Pet OTC Medication Sales Market Share by Company (2021-2026)
Table 18. Global Pet OTC Medication Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Pet OTC Medication Revenue Market Share by Company (2021-2026)
Table 20. Global Pet OTC Medication Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Pet OTC Medication Producing Area Distribution and Sales Area
Table 22. Players Pet OTC Medication Products Offered
Table 23. Pet OTC Medication Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet OTC Medication Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Pet OTC Medication Sales Market Share Geographic Region (2021-2026)
Table 28. Global Pet OTC Medication Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Pet OTC Medication Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Pet OTC Medication Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Pet OTC Medication Sales Market Share by Country/Region (2021-2026)
Table 32. Global Pet OTC Medication Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Pet OTC Medication Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 35. Americas Pet OTC Medication Sales Market Share by Country (2021-2026)
Table 36. Americas Pet OTC Medication Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 38. Americas Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 39. APAC Pet OTC Medication Sales by Region (2021-2026) & (K Units)
Table 40. APAC Pet OTC Medication Sales Market Share by Region (2021-2026)
Table 41. APAC Pet OTC Medication Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 43. APAC Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 44. Europe Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 45. Europe Pet OTC Medication Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 47. Europe Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Pet OTC Medication Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Pet OTC Medication Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Pet OTC Medication Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Pet OTC Medication Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Pet OTC Medication
Table 53. Key Market Challenges & Risks of Pet OTC Medication
Table 54. Key Industry Trends of Pet OTC Medication
Table 55. Pet OTC Medication Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet OTC Medication Distributors List
Table 58. Pet OTC Medication Customer List
Table 59. Global Pet OTC Medication Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Pet OTC Medication Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Pet OTC Medication Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Pet OTC Medication Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Pet OTC Medication Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Pet OTC Medication Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Pet OTC Medication Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Pet OTC Medication Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Pet OTC Medication Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Pet OTC Medication Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Pet OTC Medication Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Pet OTC Medication Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Bayer AG Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 74. Bayer AG Pet OTC Medication Product Portfolios and Specifications
Table 75. Bayer AG Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Bayer AG Main Business
Table 77. Bayer AG Latest Developments
Table 78. Boehringer Ingelheim International GmbH Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim International GmbH Pet OTC Medication Product Portfolios and Specifications
Table 80. Boehringer Ingelheim International GmbH Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boehringer Ingelheim International GmbH Main Business
Table 82. Boehringer Ingelheim International GmbH Latest Developments
Table 83. Covetrus Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 84. Covetrus Pet OTC Medication Product Portfolios and Specifications
Table 85. Covetrus Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Covetrus Main Business
Table 87. Covetrus Latest Developments
Table 88. Dechra Pharmaceuticals Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 89. Dechra Pharmaceuticals Pet OTC Medication Product Portfolios and Specifications
Table 90. Dechra Pharmaceuticals Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Dechra Pharmaceuticals Main Business
Table 92. Dechra Pharmaceuticals Latest Developments
Table 93. Elanco Animal Health Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Animal Health Pet OTC Medication Product Portfolios and Specifications
Table 95. Elanco Animal Health Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Elanco Animal Health Main Business
Table 97. Elanco Animal Health Latest Developments
Table 98. Heska Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 99. Heska Pet OTC Medication Product Portfolios and Specifications
Table 100. Heska Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Heska Main Business
Table 102. Heska Latest Developments
Table 103. IDEXX Laboratories Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 104. IDEXX Laboratories Pet OTC Medication Product Portfolios and Specifications
Table 105. IDEXX Laboratories Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. IDEXX Laboratories Main Business
Table 107. IDEXX Laboratories Latest Developments
Table 108. Kyoritsu Seiyaku Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 109. Kyoritsu Seiyaku Pet OTC Medication Product Portfolios and Specifications
Table 110. Kyoritsu Seiyaku Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kyoritsu Seiyaku Main Business
Table 112. Kyoritsu Seiyaku Latest Developments
Table 113. Merck & Co. Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck & Co. Pet OTC Medication Product Portfolios and Specifications
Table 115. Merck & Co. Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Merck & Co. Main Business
Table 117. Merck & Co. Latest Developments
Table 118. Phibro Animal Health Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 119. Phibro Animal Health Pet OTC Medication Product Portfolios and Specifications
Table 120. Phibro Animal Health Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Phibro Animal Health Main Business
Table 122. Phibro Animal Health Latest Developments
Table 123. Sequent Scientific Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 124. Sequent Scientific Pet OTC Medication Product Portfolios and Specifications
Table 125. Sequent Scientific Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Sequent Scientific Main Business
Table 127. Sequent Scientific Latest Developments
Table 128. Vetoquinol SA Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 129. Vetoquinol SA Pet OTC Medication Product Portfolios and Specifications
Table 130. Vetoquinol SA Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Vetoquinol SA Main Business
Table 132. Vetoquinol SA Latest Developments
Table 133. Virbac SA Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 134. Virbac SA Pet OTC Medication Product Portfolios and Specifications
Table 135. Virbac SA Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Virbac SA Main Business
Table 137. Virbac SA Latest Developments
Table 138. Zoetis Basic Information, Pet OTC Medication Manufacturing Base, Sales Area and Its Competitors
Table 139. Zoetis Pet OTC Medication Product Portfolios and Specifications
Table 140. Zoetis Pet OTC Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Zoetis Main Business
Table 142. Zoetis Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet OTC Medication
Figure 2. Pet OTC Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet OTC Medication Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pet OTC Medication Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pet OTC Medication Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pet OTC Medication Sales Market Share by Country/Region (2025)
Figure 10. Pet OTC Medication Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Product Picture of Sprays
Figure 14. Global Pet OTC Medication Sales Market Share by Type in 2026
Figure 15. Global Pet OTC Medication Revenue Market Share by Type (2021-2026)
Figure 16. Pet OTC Medication Consumed in Pet Specialty Stores
Figure 17. Global Pet OTC Medication Market: Pet Specialty Stores (2021-2026) & (K Units)
Figure 18. Pet OTC Medication Consumed in Veterinary Clinics
Figure 19. Global Pet OTC Medication Market: Veterinary Clinics (2021-2026) & (K Units)
Figure 20. Pet OTC Medication Consumed in Others
Figure 21. Global Pet OTC Medication Market: Others (2021-2026) & (K Units)
Figure 22. Global Pet OTC Medication Sale Market Share by Application (2025)
Figure 23. Global Pet OTC Medication Revenue Market Share by Application in 2026
Figure 24. Pet OTC Medication Sales by Company in 2026 (K Units)
Figure 25. Global Pet OTC Medication Sales Market Share by Company in 2026
Figure 26. Pet OTC Medication Revenue by Company in 2026 ($ millions)
Figure 27. Global Pet OTC Medication Revenue Market Share by Company in 2026
Figure 28. Global Pet OTC Medication Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Pet OTC Medication Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Pet OTC Medication Sales 2021-2026 (K Units)
Figure 31. Americas Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 32. APAC Pet OTC Medication Sales 2021-2026 (K Units)
Figure 33. APAC Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 34. Europe Pet OTC Medication Sales 2021-2026 (K Units)
Figure 35. Europe Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Pet OTC Medication Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 38. Americas Pet OTC Medication Sales Market Share by Country in 2026
Figure 39. Americas Pet OTC Medication Revenue Market Share by Country (2021-2026)
Figure 40. Americas Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 41. Americas Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 42. United States Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Pet OTC Medication Sales Market Share by Region in 2026
Figure 47. APAC Pet OTC Medication Revenue Market Share by Region (2021-2026)
Figure 48. APAC Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 49. APAC Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 50. China Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 54. India Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Pet OTC Medication Sales Market Share by Country in 2026
Figure 58. Europe Pet OTC Medication Revenue Market Share by Country (2021-2026)
Figure 59. Europe Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 60. Europe Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 61. Germany Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 62. France Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Pet OTC Medication Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 69. Egypt Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pet OTC Medication in 2026
Figure 75. Manufacturing Process Analysis of Pet OTC Medication
Figure 76. Industry Chain Structure of Pet OTC Medication
Figure 77. Channels of Distribution
Figure 78. Global Pet OTC Medication Sales Market Forecast by Region (2027-2032)
Figure 79. Global Pet OTC Medication Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Pet OTC Medication Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Pet OTC Medication Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Pet OTC Medication Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Pet OTC Medication Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pet OTC Medication
Figure 2. Pet OTC Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet OTC Medication Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pet OTC Medication Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pet OTC Medication Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pet OTC Medication Sales Market Share by Country/Region (2025)
Figure 10. Pet OTC Medication Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Product Picture of Sprays
Figure 14. Global Pet OTC Medication Sales Market Share by Type in 2026
Figure 15. Global Pet OTC Medication Revenue Market Share by Type (2021-2026)
Figure 16. Pet OTC Medication Consumed in Pet Specialty Stores
Figure 17. Global Pet OTC Medication Market: Pet Specialty Stores (2021-2026) & (K Units)
Figure 18. Pet OTC Medication Consumed in Veterinary Clinics
Figure 19. Global Pet OTC Medication Market: Veterinary Clinics (2021-2026) & (K Units)
Figure 20. Pet OTC Medication Consumed in Others
Figure 21. Global Pet OTC Medication Market: Others (2021-2026) & (K Units)
Figure 22. Global Pet OTC Medication Sale Market Share by Application (2025)
Figure 23. Global Pet OTC Medication Revenue Market Share by Application in 2026
Figure 24. Pet OTC Medication Sales by Company in 2026 (K Units)
Figure 25. Global Pet OTC Medication Sales Market Share by Company in 2026
Figure 26. Pet OTC Medication Revenue by Company in 2026 ($ millions)
Figure 27. Global Pet OTC Medication Revenue Market Share by Company in 2026
Figure 28. Global Pet OTC Medication Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Pet OTC Medication Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Pet OTC Medication Sales 2021-2026 (K Units)
Figure 31. Americas Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 32. APAC Pet OTC Medication Sales 2021-2026 (K Units)
Figure 33. APAC Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 34. Europe Pet OTC Medication Sales 2021-2026 (K Units)
Figure 35. Europe Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Pet OTC Medication Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Pet OTC Medication Revenue 2021-2026 ($ millions)
Figure 38. Americas Pet OTC Medication Sales Market Share by Country in 2026
Figure 39. Americas Pet OTC Medication Revenue Market Share by Country (2021-2026)
Figure 40. Americas Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 41. Americas Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 42. United States Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Pet OTC Medication Sales Market Share by Region in 2026
Figure 47. APAC Pet OTC Medication Revenue Market Share by Region (2021-2026)
Figure 48. APAC Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 49. APAC Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 50. China Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 54. India Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Pet OTC Medication Sales Market Share by Country in 2026
Figure 58. Europe Pet OTC Medication Revenue Market Share by Country (2021-2026)
Figure 59. Europe Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 60. Europe Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 61. Germany Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 62. France Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Pet OTC Medication Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Pet OTC Medication Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Pet OTC Medication Sales Market Share by Application (2021-2026)
Figure 69. Egypt Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Pet OTC Medication Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pet OTC Medication in 2026
Figure 75. Manufacturing Process Analysis of Pet OTC Medication
Figure 76. Industry Chain Structure of Pet OTC Medication
Figure 77. Channels of Distribution
Figure 78. Global Pet OTC Medication Sales Market Forecast by Region (2027-2032)
Figure 79. Global Pet OTC Medication Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Pet OTC Medication Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Pet OTC Medication Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Pet OTC Medication Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Pet OTC Medication Revenue Market Share Forecast by Application (2027-2032)
